---
document_datetime: 2025-03-06 09:27:47
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/bemrist-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: bemrist-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.7019244
conversion_datetime: 2025-12-27 09:36:12.859123
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Bemrist Breezhaler

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                          |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0026               | Renewal of the marketing authorisation. | 12/12/2024                          | 12/02/2025                                  | SmPC and PL                      | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Bemrist Breezhaler in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| PSUSA/10850 /202405   | Periodic Safety Update EU Single assessment - indacaterol / mometasone furoate                                                                                                                                                                                                                                                                                                                                                                                                             | 16/01/2025   | n/a   |                 |                                   |
|-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------|-----------------------------------|
| IG/1791               | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                     | 04/12/2024   |       | Annex II and PL |                                   |
| IG/1762/G             | application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where | 09/07/2024   | n/a   |                 | This was an batch control/testing |
| IG/1759/G             | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of sites                                                                                                                                                                                               | 26/06/2024   | n/a   |                 | manufacturing                     |

<div style=\"page-break-after: always\"></div>

| IG/1749/G           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                               | 11/06/2024   | n/a   |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IG/1706             | B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition                                                                                                                                                                                                                                                                                                                                                                                                            | 27/05/2024   | n/a   |                                   |
| IG/1742             | B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer                                                                                                                                                                                                                                                                                  | 30/04/2024   | n/a   |                                   |
| PSUSA/10850 /202305 | Periodic Safety Update EU Single assessment - indacaterol / mometasone furoate                                                                                                                                                                                                                                                                                                                                                                                                                               | 11/01/2024   | n/a   | PRAC Recommendation - maintenance |
| IB/0020/G           | This was an application for a group of variations. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place | 05/01/2024   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS   |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IG/1635/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                              | 11/09/2023 | n/a |

<div style=\"page-break-after: always\"></div>

| WS/2523             | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Update of sections 5.3 and 6.6 of the SmPC in order to include a statement regarding the risk to the environment based on results from ERA study Mometasone furoate - Fish Sexual Development Test with Zebrafish (Danio rerio). The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to introduce minor editorial changes to the PI. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   | 07/09/2023   | 16/09/2024   | SmPC and PL   | Mometasone is considered an endocrine active substance (EAS) and is therefore potentially harmful to aquatic life at a Predicted Environmental Concentration in surface water (PECsw) below the action limit of 0.01 Âµg/L. A GLP- compliant OECD 234 Fish Sexual Development study was carried out and as a result section 5.3 was updated to indicate that 'Environmental risk assessment studies have shown that mometasone may pose a risk to surface water.' and section 6.6. that 'This medicinal product may pose a risk to the environment (See section 5.3). Any unused medicinal product or waste material should be disposed of in accordance with local requirements.' The Package Leaflet (PL) (section 5) is updated accordingly. For more information, please refer to the Summary of Product Characteristics.   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0016/G           | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.d.1.b.1 - Stability of AS - Change in the storage conditions - Change to more restrictive storage conditions of the AS                                                                                                                                                                                                                                                                                     | 28/04/2023   | n/a          |               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| PSUSA/10850 /202205 | Periodic Safety Update EU Single assessment - indacaterol / mometasone furoate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 12/01/2023   | n/a          |               | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| N/0015              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 01/12/2022   | 16/09/2024   | PL            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

| IB/0013   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 30/08/2022   | n/a        |                        |                      |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------------------|
| IG/1511   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/05/2022   | n/a        |                        |                      |
| IB/0011/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change process | 18/01/2022   | 04/04/2022 | SmPC, Labelling and PL | in the manufacturing |

<div style=\"page-break-after: always\"></div>

| PSUSA/10850 /202105   | Periodic Safety Update EU Single assessment - indacaterol / mometasone furoate                                                                                                                                                                                                                                                                                                 | 13/01/2022   | n/a        | PRAC Recommendation - maintenance   |
|-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------------------------|
| N/0010                | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                               | 11/10/2021   | 04/04/2022 | PL                                  |
| PSUSA/10850 /202011   | Periodic Safety Update EU Single assessment - indacaterol / mometasone furoate                                                                                                                                                                                                                                                                                                 | 08/07/2021   | n/a        | PRAC Recommendation - maintenance   |
| IG/1405               | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                   | 07/07/2021   | n/a        |                                     |
| IG/1391               | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                         | 22/04/2021   | 04/04/2022 | Annex and PL                        |
| IG/1376/G             | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 14/04/2021   | n/a        |                                     |

<div style=\"page-break-after: always\"></div>

| IG/1344   | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                            | 22/03/2021   | n/a        |      |                          |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------|--------------------------|
| WS/2007   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale data)                                                                                                                                   | 11/03/2021   | 04/04/2022 | SmPC | (supported by real time  |
| IG/1300/G | This was an application for a group of variations. B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 29/10/2020   | n/a        |      |                          |
| IG/1299/G | This was an application for a group of variations. B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - (in case multiple certificates                               | 27/10/2020   | n/a        |      | Deletion of certificates |

<div style=\"page-break-after: always\"></div>

| exist per material) B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.3 - Submission deletion of Ph. Eur. Updated certificate   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|